Device Trial Radar · NCT02470494
The EarLens Contact Hearing Device (CHD) Spectrum Study
Last checked: Nov 20, 2026Latest source record: Jun 27, 2017 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
46
Actual
Start
Jun 2015
Primary completion
Jun 2016
Study completion Nov 2016
Sponsor
- Lead sponsor
- EarLens CorporationNot on our public-company list
- Sponsor type
- Industry
- First posted
- Jun 12, 2015
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years, up to 85 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The EarLens System is an assistive hearing device that is intended to provide amplification for the treatment of patients with sensorineural hearing impairment. The purpose of the proposed study (Extended Investigation under the Continued Access Policy) is to continue to allow access to the investigational medical device with the collection of device utility and clinic process-flow data while the marketing application is under review at the FDA.
Conditions
- Hearing Loss, Sensorineural
Interventions
Sound amplification provided via the EarLens CHDDevice
Subjects with mild to severe hearing impairment receiving sound amplification treatment with EarLens CHD.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change in Hearing Stability Using Unaided Air Conduction Thresholds.Time frame: Baseline and up to 90-day.
Locations
8 sites in 1 country. Site status is shown where the registry gives one.
California Hearing and Balance Center
La Jolla, California
Rodney Perkins Associates
Menlo Park, California
Camino Ear Nose and Throat Clinic
San Jose, California
5 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.